1 - 10 of 55 articles
Monoclonal antibodies, believed by many scientists to be the realization of Paul Ehrlich's decades-old "magic bullet" theory, are fast becoming the ammunition against a wide variety of diseases.
The secretory products of cells called "hybridomas" (hybrid-myelomas), monoclonal antibodies are the...
Contrary to its reputation as a uniquely effective analgesic used by British physicians to ease the pain of patients dying of cancer, heroin has emerged from clinical trials in the United States looking much like morphine, from which it is derived.
Clinical comparisons of the two agents were...
Physician advertising and contract practices seem unlikely to change immediately, and the American Medical Association's current ethical guidelines will require no dramatic changes, if a long-contested Federal Trade Commission (FTC) order becomes final next week.
Still, the order—which bans a...
It has long been an irritation to me that, after a patient experiences contrast media "reactions," physicians or other paramedical personnel will advise him never again to allow radiographic contrast agents—dyes, if you will— to be injected into him.
As a diagnostic radiologist, I have recently...
A few minutes between patients. Time to wash my hands and splash a little water on my face.
My face. Crow's-feet at my eyes... turkey wattles at my neck. And what has become of my hair?
I don't remember growing older...
My face has more character now than when I was a boy. A boy with smooth...
To the Editor.—
The recent article by Eckardt et al (1981;246:2707) has a serious flaw in the selection of controls. A control group can be defined as identical to the test group in all respects except for absence of the one factor being studied, in this case, alcoholism. In their study, at...
The possible role of β-lactamase-producing bacteria in protecting group A streptococci from the activity of penicillin is not precisely clear. As Dr Brook indicates in his letter, the reasons for high failure rates in second and third courses of penicillin are "still unknown and...
We await anxiously the result of ongoing work by Dr Brook and the confirmation of his data by others. At this time we believe it is premature to abandon penicillin treatment of group A streptococcal pharyngotonsillitis.
To the Editor.—
I read the excellent article by Schwartz et al (1981; 246:1790) and the editorial by Patricia Ferrieri, MD (1981;246:1813). These presentations dealt with the most important issue of the adequate length of treatment of group A streptococci pharyngitis. However, both the article...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.